Clinical efficacy of hand foot Wentong ointment in the treatment of hand foot syndrome caused by chemotherapy drugs
Phase 1
Recruiting
- Conditions
- Hand foot syndrome
- Registration Number
- ITMCTR2100004965
- Lead Sponsor
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients with malignant tumors confirmed by pathology or cytology;
2. Patients with grade 1 or above HFS after receiving chemotherapy;
3. Komofsky score > 60 points;
4. No serious heart, liver, kidney and other important organ dysfunction;
5. The expected survival period is more than 3 months;
6. Aged 18-80 years;
7. Good compliance;
8. Voluntarily participate and sign the informed consent.
Exclusion Criteria
1. Those with preexisting nervous system diseases;
2. Diabetes complicated with nervous system diseases;
3. Patients who are receiving other non-chemotherapy drugs that may cause neurotoxicity;
4. Uncontrolled infections and metabolic diseases;
5. Pregnant women or mentally ill patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall efficiency of HFS improvement;
- Secondary Outcome Measures
Name Time Method Improvement score of common symptoms of tumor;Improvement of quality of life score;